Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Expression Status of Fatty Acid Synthase (FAS) but Not HER2 is Correlated with the Differentiation Grade and Prognosis of Esophageal Carcinoma.

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

High Overexpression Of Fatty Acid Synthase Is Associated With Poor Survival In Chinese Patients With Gastric Carcinoma

Clinicopathological Significance of Fas and Fas Ligand Expressions in Esophageal Cancer.

A Concordant Expression Pattern of Fatty Acid Synthase and Membranous Human Epidermal Growth Factor Receptor 2 Exists in Gastric Cancer and is Associated with a Poor Prognosis in Gastric Adenocarcinoma Patients

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

Expressions of Fatty Acid Synthase and HER2 Are Correlated with Poor Prognosis of Ovarian Cancer

High FAS Expression Correlates with a Better Prognosis and Efficacy of Taxanes and Target Regents in Breast Cancer

The Expression and Clinical Signification of FAS in Colorectal Cancer

Fatty Acid Synthase Expression in Japanese Breast Carcinoma Patients

Fas/FasL Expression of Esophageal Squamous Cell Carcinoma, Dysplasia Tissues and Normal Mucosa

RETRACTED: Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer (Retracted article. See vol. 6, pg. 126, 2016)

Clinical Significance of Fatty Acid Synthase in Non-Small Cell Lung Cancer

Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma

[Clinical Significance and Expression of Fatty Acid Synthase Mrna in Lung Cancer].

Expression of Survivin, Fas and FasL and Their Prognostic Significance in Aged Patients with Esophageal Carcinoma

Prognostic and clinicopathological significance of fatty acid synthase in breast cancer: A systematic review and meta-analysis

RESPONSE: Re: Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma

FAS gene expression, prognostic significance and molecular interactions in lung cancer

Expression of Fatty Acid Synthase Negatively Correlates with PTEN and Predicts Peritoneal Dissemination of Human Gastric Cancer.

Significance of Fas and FasL Protein Expression in Cardiac Carcinoma and Local Lymph Node Tissues.